证券代码：603155 证券简称：新亚强 公告编号：2023-038 会议召开时间：2023 年 8 月 23 日(星期三) 14:00-15:00 新亚强硅化学股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会 议 召 开 地 点 ： 上海证券 交易所上证路演中心（ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 8 月 16 日(星期三) 至 8 月 22 日(星期二)16:00 前登录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公司邮箱 ir@newasiaman.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 新亚强硅化学股份有限公司（以下简称"公司"）将于 2023 年 8 月 23 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半 年 ...

2023 年第一季度报告 证券代码：603155 证券简称：新亚强 新亚强硅化学股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 1、公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财 务信息的真实、准确、完整。 3、第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 （一）主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | | 本报告期比上年同期增减 | | | --- | --- | --- | --- | --- | | | | | 变动幅度(%) | | | 营业收入 | | 226,715,678.12 | | -31.12 | | 归属于上市公司股东的净利润 | | 54,899,215.85 | | -42.59 | | 归属于上市公司股东的扣除非经常 ...

Financial Performance - The company's operating revenue for 2022 was CNY 1,133,598,652.44, representing a 28.82% increase compared to CNY 879,996,006.51 in 2021[22] - The net profit attributable to shareholders for 2022 was CNY 301,717,038.19, a decrease of 5.55% from CNY 319,444,551.13 in the previous year[22] - The net profit after deducting non-recurring gains and losses was CNY 284,406,514.11, down 2.39% from CNY 291,373,246.30 in 2021[22] - The net cash flow from operating activities increased by 57.50% to CNY 299,988,969.57, compared to CNY 190,468,110.19 in 2021[22] - The proposed cash dividend is CNY 10.00 per 10 shares, totaling CNY 225,562,000.00, along with a capital reserve conversion of 4 shares for every 10 shares held[6] - The company achieved significant production efficiency improvements and product quality enhancements through ongoing process optimization and technological innovation[34] - The company achieved operating revenue of CNY 1,133,598,652.44, an increase of 28.82% compared to the previous year[43] - Operating costs rose to CNY 785,392,756.44, reflecting a significant increase of 56.39% year-on-year, primarily due to rising raw material prices and increased production volume[45] - The company’s total assets reached CNY 2,705,163,800, a 7.97% increase from the previous year, and net assets attributable to shareholders increased by 6.64% to CNY 2,346,594,900[43] Research and Development - Research and development expenses increased by 30.89% to CNY 36,856,352.18, indicating a commitment to innovation and product development[44] - The company has established a long-term partnership with universities and research institutions, enhancing its R&D capabilities and innovation potential[41] - The company is focusing on R&D innovation to maintain its competitive edge in the organic silicon market[68] - The Shanghai R&D center has entered the installation and commissioning phase, while project design work at the Hubei facility is progressing smoothly[33] Market Expansion and Strategy - The company is actively expanding into new markets such as new energy vehicles, pharmaceuticals, and electronics, leveraging its core products' leading position in niche markets[33] - The company is accelerating the construction of projects, including a 10,000-ton annual production capacity for phenyl chlorosilane and a 2,500-ton annual production capacity for phenyl intermediates[34] - The company is optimizing its product line to meet the growing market demand in sectors such as organic silicon new materials, pharmaceuticals, and electronic chemicals[80] - The company is exploring potential mergers and acquisitions to strengthen its market position[175] Governance and Compliance - The company has established a governance structure that includes a general meeting of shareholders, a board of directors, a supervisory board, and management, ensuring clear responsibilities and checks and balances among these entities[95] - The board of directors consists of 6 members, with 3 independent directors, meeting the legal requirements and ensuring fair and effective decision-making[97] - The company has strengthened its information disclosure management, ensuring timely and accurate communication of relevant information to all shareholders[98] - The company has not faced any requests for a temporary shareholders' meeting from shareholders holding more than 10% of voting shares during the reporting period[95] Environmental and Safety Measures - The company emphasizes safety in its production processes, having achieved secondary certification for safety production standards, but acknowledges the inherent risks associated with handling hazardous chemicals[91] - Environmental protection measures are in place, including ISO 14001:2015 certification, but the company may face increased costs and regulatory challenges in the future[92] - The company invested approximately 27.99 million yuan in environmental protection during the reporting period[134] - The company has established a wastewater treatment system that complies with discharge standards, utilizing MVR evaporation and biochemical treatment processes[136] Shareholder Information - The total number of shares held by the top ten shareholders is 116,670,000, with significant increases in holdings for several key shareholders[199] - The largest shareholder, 初琳, holds 103,725,189 shares, representing 45.99% of the total shares[199] - The company plans to lift restrictions on shares for several shareholders on September 1, 2023[195] - The total number of ordinary shareholders increased from 13,137 to 14,151 during the reporting period[196] Financial Management - The company has engaged in entrusted financial management with a total amount of 220,951,000 RMB from self-owned funds and 178,000,000 RMB from raised funds[172] - The company has received returns from various entrusted financial management projects, with annualized yields ranging from 1.85% to 3.35%[172] - The company has maintained a good credit status with no defaults on court judgments or significant overdue debts[168] Risks and Challenges - The company faces risks from intensified market competition as domestic and international players expand their presence in the silicone market, potentially leading to price declines[90] - Macroeconomic fluctuations may impact the company's operations, as its business is closely tied to various downstream industries, which could affect customer demand[90]

证券代码：603155 证券简称：新亚强 公告编号：2023-006 新亚强硅化学股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 4 月 27 日(星期四) 15:00-16:00 会 议 召 开 地 点 ： 上海证券 交易所上证路演中心（ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 4 月 20 日(星期四) 至 4 月 26 日（星期三）16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过 公司邮箱 ir@newasiaman.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 新亚强硅化学股份有限公司（以下简称"公司"）将于 2023 年 4 月 25 日发 布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 4 月 2 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥275,216,940.24, representing a 25.68% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2022 was ¥73,608,275.59, showing a decrease of 10.88% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥69,101,543.48, down by 9.00% compared to the previous year[3]. - The basic earnings per share for Q3 2022 was ¥0.33, a decrease of 10.81% compared to the same period last year[3]. - The net profit for Q3 2022 was CNY 264,742,592.84, an increase of 15.4% compared to CNY 229,355,399.95 in Q3 2021[19]. - The total comprehensive income for Q3 2022 was CNY 264,742,592.84, an increase from CNY 229,355,399.95 in Q3 2021, representing a growth of 15.4%[20]. - Net profit for the first three quarters of 2022 was ¥264,289,219.25, up 15.2% from ¥229,355,399.95 in the previous year[30]. Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached RMB 940,585,075.66, a significant increase from RMB 633,377,672.84 in the same period of 2021, representing a growth of approximately 48.4%[18]. - Total operating costs for the first three quarters of 2022 were RMB 666,842,810.04, compared to RMB 402,619,339.76 in the first three quarters of 2021, indicating an increase of about 65.7%[18]. - The total revenue for the first three quarters of 2022 reached ¥940,578,279.27, a significant increase of 48.4% compared to ¥633,377,672.84 in the same period of 2021[29]. Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥256,423,754.46, an increase of 97.85%[3]. - The cash flow from operating activities for the first three quarters of 2022 was CNY 256,423,754.46, significantly higher than CNY 129,608,275.50 in the same period of 2021, marking a growth of 97.9%[22]. - The cash flow from investing activities showed a net inflow of CNY 38,903,485.43 in Q3 2022, a recovery from a net outflow of CNY -207,863,706.39 in Q3 2021[23]. - The net cash flow from operating activities for the first three quarters of 2022 was approximately ¥256.49 million, a 98% increase compared to ¥129.61 million in the same period of 2021[32]. - The net cash flow from investment activities for Q3 2022 was approximately ¥20.72 million, a significant improvement from a negative cash flow of ¥207.86 million in Q3 2021[33]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,707,557,913.27, an increase of 8.07% from the end of the previous year[4]. - Total assets as of September 30, 2022, were RMB 2,707,557,913.27, up from RMB 2,505,486,058.34 at the end of 2021, representing an increase of approximately 8.1%[15]. - Total liabilities as of September 30, 2022, were RMB 367,937,438.98, compared to RMB 305,048,176.89 at the end of 2021, indicating an increase of about 20.7%[14]. - The total liabilities as of September 30, 2022, were ¥367,908,796.97, compared to ¥305,043,169.84 at the end of 2021, indicating an increase of 20.6%[27]. Shareholder Information - The company had a total of 15,243 common shareholders at the end of the reporting period[8]. - The top shareholder, Chulin, held 45.99% of the shares, totaling 103,725,189 shares[9]. Research and Development - Research and development expenses for the first three quarters of 2022 amounted to RMB 26,084,397.73, up from RMB 19,532,144.91 in the same period of 2021, reflecting a growth of approximately 33.4%[18]. - Research and development expenses for the first three quarters of 2022 were ¥26,084,397.73, up 33.4% from ¥19,532,144.91 in 2021, highlighting a commitment to innovation[29]. Future Strategies - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided content[18]. - The company has plans for future growth strategies, including potential mergers and acquisitions, although specific details were not provided in the content[18].

Financial Performance - The company's operating revenue for 2021 was CNY 879,996,006.51, representing a 79.47% increase compared to CNY 490,329,112.07 in 2020[22]. - Net profit attributable to shareholders for 2021 reached CNY 319,444,551.13, a 103.03% increase from CNY 157,336,401.16 in 2020[22]. - The net profit after deducting non-recurring gains and losses was CNY 291,373,246.30, up 118.96% from CNY 133,073,660.69 in 2020[22]. - The company's total assets increased by 19.05% to CNY 2,505,486,058.34 at the end of 2021, compared to CNY 2,104,591,662.00 at the end of 2020[22]. - Basic earnings per share for 2021 were CNY 2.05, a 69.42% increase from CNY 1.21 in 2020[23]. - The weighted average return on equity rose to 15.38% in 2021, an increase of 1.16 percentage points from 14.22% in 2020[23]. - The net cash flow from operating activities for 2021 was CNY 190,468,110.19, a 24.03% increase from CNY 153,571,836.86 in 2020[22]. - The company reported a quarterly revenue of CNY 246,618,333.67 in Q4 2021, showing consistent growth throughout the year[25]. - The company's net assets attributable to shareholders increased by 11.89% to CNY 2,200,437,881.45 at the end of 2021, up from CNY 1,966,551,330.32 at the end of 2020[22]. Dividend and Capital Management - The company plans to distribute a cash dividend of 10.00 RMB per 10 shares, totaling 155,560,000.00 RMB (including tax) based on a total share capital of 155,560,000 shares[6]. - The company will also increase capital reserves by issuing 4.5 additional shares for every 10 shares held by shareholders[6]. - The company approved a cash dividend of 10.00 CNY per 10 shares, totaling 155,560,000.00 CNY, which represents 48.70% of the net profit attributable to shareholders for the year 2021[130]. Audit and Compliance - The company has received a standard unqualified audit report from Zhongshun Zhonghuan Accounting Firm[5]. - The audit report confirms that the financial statements of Xinyaqiang Silicon Chemical Co., Ltd. fairly reflect its financial position as of December 31, 2021, in accordance with accounting standards[200]. - The audit opinion indicates that the financial statements are free from material misstatement and provide a true and fair view of the company's financial results[200]. - The company is committed to adhering to enterprise accounting standards in its financial reporting[200]. - The company has established a robust corporate governance structure, ensuring compliance with relevant laws and regulations[98]. Research and Development - The company added 19 new authorized patents during the reporting period, contributing to sustainable high-quality development[32]. - The company’s R&D efforts led to the establishment of a new research center in Shanghai, enhancing innovation capabilities[38]. - R&D expenses increased by 56.16% to CNY 28,158,869.81, representing 3.20% of total operating revenue[54]. - The company is actively expanding its product lines in the organic silicon industry, focusing on high-end applications[38]. - The company is committed to strengthening collaboration with universities and research institutions to enhance the relevance and foresight of product development[91]. Market and Competitive Position - The company’s market share for key products has further increased, particularly in high-growth sectors such as new energy and new materials[33]. - The company faces intensified market competition due to the rapid growth of domestic organic silicon enterprises and potential price declines[92]. - The company anticipates continued rapid growth in product prices and market demand due to the expansion of strategic emerging industries such as new energy vehicles and 5G technology[89]. - The company is a leading manufacturer in the organic silicon functional additives and phenyl chlorosilane products sector, with strong market competitiveness and recognition from international giants[66]. Environmental and Social Responsibility - The company has obtained ISO 14001:2015 certification for its environmental management system, emphasizing its commitment to environmental protection[94]. - The company has established a wastewater treatment system that complies with discharge standards, utilizing MVR evaporation and biochemical treatment processes[139]. - The company actively fulfills its social responsibilities, focusing on integrity, compliance, safety, and environmental protection[146]. Investor Relations and Governance - The company emphasizes transparency in information disclosure, ensuring all shareholders have equal access to information[100]. - The company has established a dedicated department for daily investor relations management, ensuring compliance and transparency in investor communications[101]. - The company has conducted multiple shareholder meetings to discuss annual reports and financial decisions, ensuring shareholder engagement[102]. - The company has a structured approach to managing its investor relations, which is expected to enhance governance and maximize overall corporate benefits[101]. Financial Management and Investments - The company has engaged in wealth management with a total investment of RMB 367,700,000, including RMB 153,200,000 from self-owned funds and RMB 214,500,000 from raised funds[172]. - The company has a diversified investment strategy, utilizing both fixed income and floating income types in its financial management[180]. - The total amount of entrusted financial management by China Bank in 2021 reached CNY 20,500 million, with a minimum return type and an annualized yield of 1.50%[176]. - The actual return or loss for the entrusted financial management by China Bank was CNY 388.07 million, reflecting a loss of -3.97%[176]. Future Outlook - The company plans to enhance its production capacity and accelerate technological innovation in 2022, focusing on semiconductor, new energy, and high-end new materials applications[91]. - The company has set a performance guidance of 10% revenue growth for 2022, driven by new product launches and market expansion[107]. - The management team emphasized the importance of digital transformation, with a target of increasing online sales by 25%[107].